Testicular cancer is an uncommon malignancy in men and is curable in most instances. There is marked geographical variation with age-standardized rate (ASR) per 100,000 ranging from 4.6 in developed countries to 0.8 in developing countries 1 . The incidence of testicular cancer is highest in Western and Northern Europe, Australia, and North America, while the lowest incidence is in Asia and Africa 2 . Despite its low overall incidence, it is the most common cancer in young men, in the third or fourth decade of life 3 . The incidence of testicular cancer has been increasing over the past four decades, while mortality rate has been decreasing in most European countries 4–6 . Over 71,000 new testicular cancer cases and 9,500 deaths are estimated to occur worldwide in 2018 7 .
展开▼
